Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Author Guidelines

The Journal of Advances in Drug Research (JADR) welcomes original and high-quality manuscripts in the fields of drug discovery, pharmaceutical sciences, medicinal chemistry, pharmacology, toxicology, biochemistry, pharmacognosy, biotechnology, pharmaceutical technology, and related interdisciplinary areas.

Authors are requested to carefully follow the guidelines below before submitting a manuscript.

1. Types of Manuscripts

The journal accepts the following types of submissions:

  • Original Research Articles

  • Review Articles

  • Short Communications

  • Case Studies

  • Methodological Articles

  • Research Notes

  • Scientific Reviews

  • Letters to the Editor

2. Language

Manuscripts must be written in clear and professional English.

Authors whose first language is not English are encouraged to carefully review the manuscript for grammar, terminology, and scientific clarity before submission.

3. Manuscript Format

Manuscripts should be submitted in Microsoft Word format (.doc or .docx).

Recommended formatting:

  • Paper size: A4

  • Font: Times New Roman

  • Font size: 12 pt

  • Line spacing: 1.5

  • Margins: 2.5 cm on all sides

  • Text alignment: Justified

  • Page numbers: Required

  • Manuscript language: English

4. Manuscript Length

As a general recommendation:

  • Original Research Article: 3,000–7,000 words

  • Review Article: 4,000–10,000 words

  • Short Communication: 1,500–3,000 words

  • Case Study: 1,500–4,000 words

The journal may consider longer manuscripts when scientifically justified.

5. Title Page

The title page should include:

  • Full title of the manuscript

  • Full names of all authors

  • Institutional affiliations

  • Department, institution, city, and country

  • ORCID ID, if available

  • Email address of the corresponding author

  • Corresponding author's contact information

The manuscript title should be concise, informative, and directly related to the research.

6. Abstract

Each manuscript should include a structured or unstructured abstract of approximately 150–300 words.

For original research articles, the abstract should preferably include:

  • Background

  • Objective

  • Methods

  • Results

  • Conclusion

The abstract should clearly summarize the major purpose, methods, findings, and conclusions of the study.

7. Keywords

Authors should provide 4–8 keywords immediately after the abstract.

Keywords should accurately represent the main concepts of the manuscript and should not unnecessarily repeat words already used in the title.

8. Structure of Original Research Articles

Original research articles should generally follow the IMRAD structure:

Introduction

The Introduction should explain the scientific background, research problem, relevant literature, and objective of the study.

Materials and Methods

This section should provide sufficient information to allow the study to be understood and, where appropriate, reproduced.

Authors should describe:

  • Study design

  • Materials

  • Chemicals and reagents

  • Instruments

  • Experimental procedures

  • Sample preparation

  • Statistical methods

  • Ethical approval, where applicable

Results

The Results section should present the major findings clearly and logically.

Tables and figures may be used where they improve understanding of the findings.

Discussion

The Discussion should interpret the results, compare them with relevant scientific literature, discuss their importance, and identify limitations where appropriate.

Conclusion

The Conclusion should briefly summarize the main scientific findings and their significance.

9. Review Articles

Review articles should provide a critical, balanced, and up-to-date analysis of the available scientific literature.

A review article should normally include:

  • Abstract

  • Keywords

  • Introduction

  • Main thematic sections

  • Critical discussion

  • Future perspectives, where applicable

  • Conclusion

  • References

10. Tables

Tables should:

  • Be numbered consecutively

  • Have a clear and descriptive title

  • Be cited in the manuscript text

  • Contain explanatory notes where necessary

  • Avoid unnecessary duplication of information already presented in the text

Example:

Table 1. Physicochemical properties of the investigated compounds

11. Figures and Illustrations

Figures, graphs, photographs, chemical structures, and other illustrations should be of sufficient quality for publication.

Authors should:

  • Number figures consecutively

  • Provide a clear figure caption

  • Refer to every figure in the manuscript text

  • Ensure labels and text are readable

  • Submit high-resolution images where possible

Authors are responsible for obtaining permission to reproduce copyrighted figures or images from other publications.

12. Chemical Structures and Equations

Chemical structures, reaction schemes, molecular diagrams, and equations should be clear, accurate, and properly numbered where necessary.

Standard chemical nomenclature should be used throughout the manuscript.

13. Abbreviations

Abbreviations should be defined when first used.

Only internationally recognized abbreviations should be used without explanation.

Excessive or unnecessary abbreviations should be avoided.

14. Units of Measurement

Authors should use the International System of Units (SI) wherever possible.

Units, symbols, chemical names, and scientific terminology should be used consistently throughout the manuscript.

15. References

References should be relevant, accurate, and sufficiently recent for the subject of the manuscript.

All references cited in the text must appear in the reference list, and all references listed must be cited in the manuscript.

Authors should provide complete bibliographic details, including:

  • Author names

  • Article title

  • Journal or book title

  • Year

  • Volume

  • Issue, where applicable

  • Page numbers

  • DOI, where available

Example:

Smith JA, Kumar R, Patel S. Novel approaches in pharmaceutical drug development. Journal of Pharmaceutical Research. 2024;18(2):115–126. https://doi.org/xxxxx

16. In-Text Citations

Authors should use one consistent citation style throughout the manuscript.

Citation formatting should correspond exactly with the final reference list.

17. Ethical Requirements

Research involving humans, animals, clinical samples, or sensitive biological material must comply with recognized ethical standards.

Where applicable, authors should provide:

  • Name of the ethics committee

  • Approval number

  • Date of approval

  • Informed consent information

Animal studies should follow appropriate institutional and international animal welfare standards.

18. Clinical Trials

Clinical studies should provide trial registration information where applicable.

Authors should clearly describe:

  • Study design

  • Participant selection

  • Intervention

  • Outcomes

  • Ethical approval

  • Informed consent

  • Registration details

19. Originality

Submitted manuscripts must represent original work.

The manuscript must not:

  • Have been previously published in substantially the same form

  • Be simultaneously under consideration by another journal

  • Contain fabricated or falsified data

  • Include unattributed material from other sources

Authors are responsible for ensuring the originality and integrity of their work.

20. Plagiarism and Similarity

All submitted manuscripts may be evaluated for textual similarity.

Authors should properly cite and reference all material derived from other sources.

Excessive similarity, plagiarism, self-plagiarism, data manipulation, or inappropriate duplication may result in rejection or further editorial action.

21. Authorship

All listed authors should have made a meaningful contribution to the research or preparation of the manuscript.

The corresponding author is responsible for confirming that:

  • All authors have approved the final manuscript

  • All authors agree to submission

  • The author list is accurate

  • Appropriate acknowledgements have been included

22. Conflict of Interest

Authors must disclose any financial, professional, institutional, or personal relationships that could potentially influence the research.

If no conflict exists, authors may state:

Conflict of Interest: The authors declare no conflict of interest.

23. Funding

All sources of financial support should be disclosed.

If the research received no specific funding, authors may state:

Funding: This research received no external funding.

24. Acknowledgements

Individuals or organizations that contributed to the study but do not meet authorship criteria may be acknowledged.

Permission should be obtained where necessary before naming individuals in the acknowledgement section.

25. Data Availability

Authors are encouraged to provide a data availability statement where appropriate.

Example:

Data Availability Statement: The data supporting the findings of this study are available from the corresponding author upon reasonable request.

26. Supplementary Materials

Additional datasets, figures, tables, protocols, or multimedia materials may be submitted as supplementary files where appropriate.

Supplementary materials should be clearly identified and referenced in the manuscript.

27. Peer Review

Manuscripts submitted to JADR are subject to editorial assessment and peer review.

The editorial team may:

  • Accept the manuscript

  • Request minor revision

  • Request major revision

  • Reject the manuscript

Authors should respond carefully to reviewer and editorial comments when submitting a revised version.

28. Revised Manuscripts

When submitting a revision, authors should provide:

  • Revised manuscript

  • Response to reviewers

  • Clear explanation of changes made

  • Highlighted or tracked changes, if requested by the editor

Responses should be professional, clear, and point-by-point.

29. Copyright and Permissions

Authors are responsible for ensuring that submitted material does not violate third-party copyright.

Permission must be obtained for copyrighted tables, illustrations, images, or substantial reproduced material where required.

30. Submission Checklist

Before submitting the manuscript, authors should confirm that:

  • The manuscript is original and has not been submitted elsewhere.

  • The manuscript file is in Microsoft Word format.

  • The title page contains complete author information.

  • The corresponding author is clearly identified.

  • The abstract and keywords are included.

  • The manuscript follows an appropriate scientific structure.

  • Tables and figures are properly numbered and cited.

  • References are complete and consistent.

  • Ethical approval information is included where applicable.

  • Conflict of interest and funding statements are provided.

  • All authors have approved the final manuscript.

  • The manuscript has been checked for language, grammar, and scientific clarity.

Submission

Manuscripts should be submitted through the online submission system of the Journal of Advances in Drug Research (JADR).

________________________________________________________________________________________________________

 

Articles

Section default policy

Privacy Statement

Privacy Statement

The Journal of Advances in Drug Research (JADR) is committed to protecting the privacy and confidentiality of authors, reviewers, editors, readers, and other users of the journal website.

The names, email addresses, institutional affiliations, telephone numbers, and other personal information entered on this journal website will be used exclusively for the stated purposes of the journal. Such information will not be made available to third parties for commercial purposes without the consent of the individual concerned.

Personal information may be collected for purposes including manuscript submission, peer review, editorial communication, publication management, account administration, and delivery of journal-related information.

Authors are responsible for ensuring that any personal information concerning co-authors or other individuals included in submitted manuscripts has been provided with appropriate authorization where required.

Reviewer identities and confidential peer-review information will be handled in accordance with the journal’s peer-review policies. Unpublished manuscripts, reviewer comments, editorial correspondence, and other confidential materials will not be disclosed to unauthorized persons.

The journal may collect basic technical information, such as IP addresses, browser information, and website usage data, for the purposes of website administration, security, performance monitoring, and improving user experience.

Users are responsible for maintaining the confidentiality of their account credentials and should not share their passwords with unauthorized persons.

The journal will take reasonable measures to protect stored personal and editorial information against unauthorized access, loss, misuse, alteration, or disclosure.

By registering, submitting a manuscript, or otherwise using the journal website, users acknowledge that their information may be processed as necessary for the operation of the journal and its scholarly publishing activities.

The Journal of Advances in Drug Research reserves the right to update this Privacy Statement when necessary to reflect changes in journal procedures, website functionality, or applicable policies.

For questions concerning privacy or the use of personal information, users may contact the journal through its official website:

Journal of Advances in Drug Research (JADR)
ISSN: 2230-7761
Website: www.jadr.co.in